Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy
暂无分享,去创建一个
C E Elger | C. Elger | H. Beck | I. Blümcke | A. Kudin | W. Kunz | W. Zuschratter | S. Vielhaber | H Beck | W Zuschratter | W S Kunz | I Blümcke | J Schramm | A P Kudin | S Vielhaber | J. Schramm
[1] Reinhart Heinrich,et al. A Linear Steady-State Treatment of Enzymatic Chains Critique of the Crossover Theorem and a General Procedure to Identify Interaction Sites with an Effector , 1974 .
[2] T. Peng,et al. Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.
[3] C E Elger,et al. Cellular pathology of hilar neurons in Ammon's horn sclerosis , 1999, The Journal of comparative neurology.
[4] C. Elger,et al. Metabolic Consequences of the Cytochrome c Oxidase Deficiency in Brain of Copper‐Deficient Movbr Mice , 1999, Journal of neurochemistry.
[5] D. Wallace,et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation , 1990, Cell.
[6] M. Schuelke,et al. Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNA(Ser(UCN)) mutation. , 1998, Annals of neurology.
[7] K. Nihei,et al. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). , 1990, Biochemical and biophysical research communications.
[8] J H Margerison,et al. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. , 1966, Brain : a journal of neurology.
[9] B. Miller,et al. Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration , 1998, Annals of neurology.
[10] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[11] A. Schapira,et al. Mitochondrial DNA Mutations and Mitochondrial Dysfunction in Epilepsy , 1999, Epilepsia.
[12] H. Kacser,et al. The control of flux. , 1995, Biochemical Society transactions.
[13] Reinhart Heinrich,et al. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. , 1974, European journal of biochemistry.
[14] W. Turski,et al. Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. , 1998, European journal of pharmacology.
[15] G. Davey,et al. Energy Thresholds in Brain Mitochondria , 1998, The Journal of Biological Chemistry.
[16] 間島寧興. 早期アルツハイマー病におけるin vivo [31]P-Magnetic Resonance Spectroscopy , 1996 .
[17] F. Fonnum,et al. An In Vivo Model for Studying Function of Brain Tissue Temporarily Devoid of Glial Cell Metabolism: The Use of Fluorocitrate , 1987, Journal of neurochemistry.
[18] Ole A. Andreassen,et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.
[19] R. Kuzniecky,et al. In vivo 31P nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy , 1992, Neurology.
[20] C. Elger,et al. Quantitative investigation of mitochondrial function in single rat hippocampal slices: a novel application of high-resolution respirometry and laser-excited fluorescence spectroscopy. , 1999, Brain research. Brain research protocols.
[21] H. Bergmeyer. Methoden der enzymatischen Analyse , 1962 .
[22] M. Schuelke,et al. Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNASer(UCN) mutation , 1998, Annals of neurology.
[23] Conrad V. Kufta,et al. Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography , 1992, Annals of neurology.
[24] C. Elger,et al. Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. , 2000, Analytical biochemistry.
[25] D. Holtzman,et al. Creatine Increases Survival and Suppresses Seizures in the Hypoxic Immature Rat , 1998, Pediatric Research.